Brucellosis in cases of end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 23, Issue 7, 2008, Pages 2344-2349

  Turunç, Tuba ^a   Demiroǧlu, Yusuf Ziya ^a   Alişkan, Hikmet ^a   Çolakoǧlu, Şule ^a   Timurkaynak, Funda ^a   Özdemir, Nurhan ^a   Arslan, Hande ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Brucellosis; End stage renal diseases

Indexed keywords

BACTERIUM ANTIBODY; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD CULTURE; BRUCELLA MELITENSIS; BRUCELLOSIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; INTERVERTEBRAL DISK DEGENERATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ARTHRALGIA; BRUCELLA MELITENSIS; BRUCELLOSIS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; TREATMENT OUTCOME; TURKEY;

EID: 46849122874     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm925     Document Type: Article

References (28)

1. Pappas G, Akritidis N, Bosilkovski M et al. Brucellosis. N Engl J Med 2005; 352: 2325-2336
2. Acchiardo S, Kraus A, Jennings BR. Beta-2 microglobulin levels in patients with renal insufficiency. Am J Kidney Dis 1989; 13: 70-74
3. Sungur C, Sungur A, Gedikoglu G et al. Fatal Brucella melitensis endocarditis in a hemodialysis patient. Nephron. 1994; 67: 234-235
4. Stich-Kreitner V, Piper C, Schassan HH et al. A rare cause of infection in chronic dialysis patients. Malta fever (febril undulans melitensis). Klin Wochenschr 1988; 66: 743-746
5. Taskopan H, Oymak O, Sumerkan B et al. Brucella peritonitis in a patient on continuous ambulatory peritoneal dialysis with acute brucellosis. Nephron 2002; 91: 156-158
6. Ozisik L, Akman B, Huddam B et al. Isolated Brucella peritonitis in CAPD patient. Am J Kidney Dis 2006; 47: 65-66
7. Statistical data of Infectious Diseases Unit, Turkish Republic Ministry of Health, 2003
8. World Health Organization. Fact Sheet N173. Geneva, Switzerland: World Health Organization, 1997
9. Araj GF. Human brucellosis: a classical infectious disease with persistent diagnostic challenges. Clin Lab Sci 1999; 12: 207-212
10. Aygen B, Doganay M, Sümerkan B et al. Clinical manifestations, complications and treatment of brucellosis:a retrospective evaluation of 480 patients. Medecine et maladies infectieuses 2002; 32: 485-493
11. Colmenero JD, Reguera JM, Martos F et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 74: 195-211
12. Gur A, Geyik MF, Dikici B et al. Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey. Yonsei Med J 2003; 44: 33-44
13. Tasova Y, Saltoglu N, Sahin G et al. Osteoarthricular involvement of brucellosis in Turkey. Clin Rheumatol 1999; 18: 214-219
14. Geyik MF, Gür A, Nas K et al. Musculoskeletal involvement in brucellosis in different age groups: a study of 195 cases. Swiss Med Wkly 2002; 132: 98-105
15. Raptopaulou A, Karantanas A, Poumboulidis K et al. Brucella spondylodiscitis: non-contiguous multifocal involvement of the cervical, thoracic, and lumbar spine. Clin Imaging 2006; 30: 214-217
16. Ozden M, Demirdag K, Kalkan A et al. A case of brucellar spondylodiscitis with extended, multiple level involvement. South Med J 2005; 98: 229-231
17. Baqer MM, Quartom MA, Abdulhadi Ali Al-Ajmi J, Collier BD, Elgazzar AH. Multifocal brucellosis spondylodiscitis. Clin Nucl Med 2001; 27: 842-843
18. Bouza E, Garcia De La Torre M, Parras M et al. Brucellar meningitis. Rev Infect Dis 1987; 9: 810-822
19. McClean DR, Russel N, Khan Y. Neurobrucellosis and therapeutic features. Clin Infect Dis 1992; 15: 582-590
20. Thomas R, Kameswaran M, Murugan V et al. Sensorineural hearing loss in neurobrucellosis. J Laryngol Otol 1993; 107: 1034-1036
21. Solera J, Martinez-Alfaro E, Espinosa A. Recognition and optimum treatment of brucellosis. Drugs 1997; 53: 245-256
22. Young EJ. Brucella species. In: Mandell GL, Bennet JE, Dolin R (eds). Principles and Practice Infectious Diseases, . Philadelphia: Churchill Livingstone, 2005, 2669-2674
23. Yavuz T, Ozaydin M, Ulusan V et al. A case of mitral stenosis complicated with seronegative Brucella endocarditis. Jpn Heart J 2004; 45: 353-358
24. Potasman I, Even L, Banai M et al. Brucellosis: an unusual diagnosis for a seronegative patient with abscesses, osteomyelitis, and seronegative colitis. Rev Infect Dis 1991; 13: 1039-1042
25. Ariza J. Brucellosis. Curr Opin Infect Dis 1996; 9: 126-131
26. Solera J, Martinez-Alfaro E, Espinosa A et al. Multivariate model for predicting relapse in human brucellosis. J Infect 1998; 36: 85-92
27. Solera J, Rodriguez Zabata M, Geijo P et al. Doxycycline-rifampin versus doxycycline streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob Agents Chemother 1995; 39: 2061-2067
28. Agalar C, Usubutun S, Türkyilmaz R. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the brusellosis. Eur J Clin Microbiol Infect Dis 1999; 18: 535-538